Mark Cavendish's Tour de France preparations have taken another blow after he was struck down with glandular fever.
The Manxman will be sidelined for at least two weeks after contracting the infection through the Epstein Barr Virus.
Cavendish was already out of action with an ankle injury that forced him to miss Sunday's Paris-Roubaix.
Now his scheduled return is unclear as Team Dimension Data medical staff monitor his recovery ahead of the Tour's opening stage on July 1 in Dusseldorf.
"Mark has been experiencing some unexplained fatigue during training," team doctor Jarrad Van Zuydam said in a statement.
"Recent blood analysis has revealed him to have infectious mononucleosis caused by the Epstein Barr Virus. Unfortunately, there is no effective specific treatment against the virus, but rest will be required to aid his recovery.
"His training load and symptoms will be monitored very carefully and he will make a gradual, step-wise return to full training and racing.
"It is difficult to give an accurate estimate of when we can expect him back at full fitness, but we are hopeful of a significant improvement of his symptoms over the next two weeks."
Cavendish is only four stage wins behind Eddy Merckx all-time Tour record of 34.